Eledon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.35-$4.96 |
Market Cap | $147.8M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.30 |
News
See moreYahoo Finance • 2 months ago
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Yahoo Finance • 2 months ago
Eledon Pharmaceuticals GAAP EPS of -$0.21
Yahoo Finance • 2 months ago
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
About
CEO | Dr. David-Alexandre C. Gros M.D., Ph.D. |
Address | 19800 MacArthur Boulevard, Irvine, CA, United States, 92612 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 31 |
